Shuhao Xiao

Shuhao Xiao

Auto-generated profile, based on publicly available information

Shuhao Xiao

École Polytechnique Fédérale de Lausanne

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2021 in Science Immunology
Verified
Journal Article
Closed access
MSMurillo Silva
Murillo Silva
YKYu Kato
Yu Kato
MMMariane Bandeira Melo
Mariane Bandeira Melo
IPIvy Phung
Ivy Phung
BFBrian L. Freeman
Brian L. Freeman
DIDarrell J. Irvine
Darrell J. Irvine
An adjuvant composed of saponin and a TLR4 agonist acts by enhancing lymph flow and antigen entry into lymph nodes.

27 January 2023 in Science
Verified
Journal Article
Closed access
AAAereas Aung
Aereas Aung
ACAng Cui
Ang Cui
LMLaura Maiorino
Laura Maiorino
AAAva P. Amini
Ava P. Amini
JGJustin R. Gregory
Justin R. Gregory
DIDarrell J. Irvine
Darrell J. Irvine
The structural integrity of vaccine antigens is critical to the generation of protective antibody responses, but the impact of protease activity on vaccination in vivo is poorly understood. We characterized protease activity in lymph nodes and found that antigens were rapidly degraded in the subcapsular sinus, paracortex, and interfollicular regions, whereas low protease activity and antigen degradation rates were detected in the vicinity of follicular dendritic cells (FDCs). Correlated with these findings, immunization regimens designed to target antigen to FDCs led to germinal centers dominantly targeting intact antigen, whereas traditional immunizations led to much weaker responses that equally targeted the intact immunogen and antigen breakdown products. Thus, spatially compartmentalized antigen proteolysis affects humoral immunity and can be exploited.

13 August 2026 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
PGPius Galli
Pius Galli
SXShuhao Xiao
Shuhao Xiao
YMYanxiang Meng
Yanxiang Meng
AHAlexander Hanzl
Alexander Hanzl
ABAlexandra M. Bendel
Alexandra M. Bendel
NTNicolas H. Thomä
Nicolas H. Thomä
Molecular glue degraders (MGDs), such as pomalidomide, induce degradation of non-native substrates by the cullin-RING E3 ligase 4 (CRL4) through its substrate receptor cereblon (CRBN). Here, to explore CRBN programmability, we tested whether reported CRBN–MGD substrates are part of a network of latent CRBN interactors, proteins capable of MGD-induced CRBN binding without detectable degradation. Leveraging a highly parallel protein complementation assay (GluePCA) to measure MGD-induced interaction between CRBN and zinc fingers, we identified ~210 zinc fingers bound to CRBN–pomalidomide, where top binders are already reported as degraded by dedicated MGDs. To map latent CRBN–MGD interactions proteome-wide and define the accessible CRBN interaction space, we combined artificial intelligence-derived protein surface queries (MaSIF-mimicry) with GluePCA. This pipeline identified 6 known and 43 novel CRBN–pomalidomide binders, including orthogonally validated hits. We find that these binders provide privileged starting points for MGD development. We expect this binding-focused workflow to be applicable to other MGD–E3 ligase systems, potentially extending the scope of this emerging drug class.

11 November 2026 in bioRxiv
Verified
Preprint
Open access
EBErick Bermúdez-Méndez
Erick Bermúdez-Méndez
SOSebastian Ols
Sebastian Ols
LCLeonardo V. Cufaro
Leonardo V. Cufaro
SXShuhao Xiao
Shuhao Xiao
ZPZhitong Peng
Zhitong Peng
KLKarin Loré
Karin Loré
Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV), members of the Pneumoviridae family, circulate widely and are leading causes of hospitalization for acute respiratory infections in infants and older adults. The viral fusion (F) protein in its prefusion (preF) conformation is the primary target of neutralizing antibodies, yet how naturally elicited circulating polyclonal antibodies are distributed across its antigenic landscape remains poorly understood. Here, we combined serological profiling, site-specific antibody competition assays and electron microscopy-based polyclonal epitope mapping (EMPEM) to characterize preF-directed immunity to RSV and hMPV in healthy adults. All donors exhibited detectable preF-binding antibodies that positively correlated with virus neutralization and broadly recognized multiple antigenic sites, consistent with immunodominance patterns predicted by a surface-centric computational model. Despite this overall similarity, the distribution of responses across individual antigenic sites differed between RSV and hMPV. EMPEM analyses revealed consistent targeting of the highly neutralization-sensitive preF apex (site Ø) in both viruses, alongside less abundant responses against equatorial and upper-middle epitopes (sites II, III, IV and V). We additionally observed antibody-bound destabilized preF, supporting a model in which antibody binding promotes transient opening of the preF trimer and may interfere with the conformational rearrangements required for membrane fusion. Together, these findings highlight apex-directed antibodies as a prominent feature of naturally acquired pneumovirus immunity in adults and reveal both shared and distinct patterns of antigenic recognition that may inform next-generation vaccine design and antibody-based prophylactics.